Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Prabhleen Chahal

Gastroenterology San Antonio, TX Medical Doctor

NPI 1841265527 CMS profile 356576

8300 Floyd Curl Dr, San Antonio, TX 78229

Open in the dashboard

General payments

$63,255

91 records reported · program years 2019–2025

Research payments

$1,750

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$105,218 paid to institutions, not to them · program years 2021–2023

Through program year 2025, Prabhleen Chahal of San Antonio, TX is reported in the CMS Open Payments database as having received $63,255 across 91 general payments and $1,750 in research payments paid to them. Separately, studies naming them as principal investigator received $105,218 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,560 14
2024 General $2,019 11
2023 General $14,327 22
2022 General $18,778 19
2022 Research $1,750 2
2021 General $3,375 3
2020 General $1,565 6
2019 General $1,631 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Prabhleen Chahal
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Prabhleen Chahal were reported at $21,560. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Prabhleen Chahal Gastroenterology median Middle half National median
2019 $1,631 $417 $126–$1,100 $163
2020 $1,565 $224 $74–$624 $114
2021 $3,375 $352 $106–$1,054 $132
2022 $18,778 $448 $129–$1,270 $149
2023 $14,327 $533 $150–$1,390 $160
2024 $2,019 $605 $160–$1,606 $164
2025 $21,560 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $57,845 73 payments
  2. Medtronic, Inc. $4,789 8 payments
  3. Covidien LP $181 2 payments
  4. Cook Medical LLC $123 1 payment
  5. Olympus America Inc. $87 1 payment
  6. Endogastric Solutions, Inc $70 1 payment
  7. Steris Corporation $54 1 payment
  8. PENTAX of America, Inc. $48 1 payment
  9. FUJIFILM Medical Systems USA, Inc. $26 1 payment
  10. Merck Sharp & Dohme Corporation $17 1 payment
  11. Other $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $44,700 16 payments
  2. Consulting Fee $10,300 5 payments
  3. Travel and Lodging $4,415 25 payments
  4. Food and Beverage $3,840 45 payments
Products named General payments · program years 2019–2025
  1. General - Therapies General - Therapies_ENDO $26,707 16 payments
  2. ACCOLADE SR $7,310 3 payments
  3. Axios Axios_ENDO $5,879 12 payments
  4. General - Therapies Therapies $1,361 3 payments
  5. General Therapies $1,053 9 payments
  6. SpyGlass Spyglass DS_ENDO $790 3 payments
  7. SpyGlass SpyGlass_ENDO $259 2 payments
  8. NEXPOWDER $231 2 payments
  9. AXIOS Stents $216 2 payments
  10. GENERAL - BILIARY DEVICES $200 2 payments
  11. Other $1,512 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $1,750 2 payments

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$14,680

Medicare's payments for the services billed

Medicare patients

87

Average age 70

Services billed

142

50 women, 37 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Chronic kidney disease 44%
Depression 43%
Diabetes 38%
Ischemic heart disease 33%
Atrial fibrillation 31%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record